Shock termination of tachycardia

Paul A. Friedman; Charles D. Swerdlow

doi:10.1007/978-3-030-28533-3_166

Shock termination of tachycardia

Paul A. Friedman, Charles D. Swerdlow

Cardiovascular Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

A 68-year-old man with ischemic cardiomyopathy (NYHA Class II, left-ventricular ejection fraction 26%) underwent implantation of a prophylactic dual-chamber ICD (Medtronic EnTrust™ D154ATG) 2 years ago. His medications include lisinopril 20 mg daily, carvedilol 12.5 mg daily, simvastatin 40 ms daily, and aspirin 325 mg daily. The ICD was programmed for single zone detection. Six months ago, he had presyncope followed by a shock. ICD interrogation showed ineffective antitachycardia pacing followed by a successful shock for VT with AV dissociation at cycle length 240 ms. Diagnosis and management are discussed.

Original language	English (US)
Title of host publication	Cardiac Electrophysiology
Subtitle of host publication	Clinical Case Review
Publisher	Springer International Publishing
Pages	667-671
Number of pages	5
ISBN (Electronic)	9783030285333
ISBN (Print)	9783030285319
DOIs	https://doi.org/10.1007/978-3-030-28533-3_166
State	Published - Jan 1 2020

Keywords

Aspirin
Cardiomyopathy
Carvedilol
Pacemaker
Simvastatin
Warfarin

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-3-030-28533-3_166

Cite this

@inbook{73b9b9d5702041dc9031812a0e015cf1,

title = "Shock termination of tachycardia",

abstract = "A 68-year-old man with ischemic cardiomyopathy (NYHA Class II, left-ventricular ejection fraction 26%) underwent implantation of a prophylactic dual-chamber ICD (Medtronic EnTrust{\texttrademark} D154ATG) 2 years ago. His medications include lisinopril 20 mg daily, carvedilol 12.5 mg daily, simvastatin 40 ms daily, and aspirin 325 mg daily. The ICD was programmed for single zone detection. Six months ago, he had presyncope followed by a shock. ICD interrogation showed ineffective antitachycardia pacing followed by a successful shock for VT with AV dissociation at cycle length 240 ms. Diagnosis and management are discussed.",

keywords = "Aspirin, Cardiomyopathy, Carvedilol, Pacemaker, Simvastatin, Warfarin",

author = "Friedman, {Paul A.} and Swerdlow, {Charles D.}",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/978-3-030-28533-3_166",

language = "English (US)",

isbn = "9783030285319",

pages = "667--671",

booktitle = "Cardiac Electrophysiology",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Shock termination of tachycardia

AU - Friedman, Paul A.

AU - Swerdlow, Charles D.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - A 68-year-old man with ischemic cardiomyopathy (NYHA Class II, left-ventricular ejection fraction 26%) underwent implantation of a prophylactic dual-chamber ICD (Medtronic EnTrust™ D154ATG) 2 years ago. His medications include lisinopril 20 mg daily, carvedilol 12.5 mg daily, simvastatin 40 ms daily, and aspirin 325 mg daily. The ICD was programmed for single zone detection. Six months ago, he had presyncope followed by a shock. ICD interrogation showed ineffective antitachycardia pacing followed by a successful shock for VT with AV dissociation at cycle length 240 ms. Diagnosis and management are discussed.

AB - A 68-year-old man with ischemic cardiomyopathy (NYHA Class II, left-ventricular ejection fraction 26%) underwent implantation of a prophylactic dual-chamber ICD (Medtronic EnTrust™ D154ATG) 2 years ago. His medications include lisinopril 20 mg daily, carvedilol 12.5 mg daily, simvastatin 40 ms daily, and aspirin 325 mg daily. The ICD was programmed for single zone detection. Six months ago, he had presyncope followed by a shock. ICD interrogation showed ineffective antitachycardia pacing followed by a successful shock for VT with AV dissociation at cycle length 240 ms. Diagnosis and management are discussed.

KW - Aspirin

KW - Cardiomyopathy

KW - Carvedilol

KW - Pacemaker

KW - Simvastatin

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=85089631592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089631592&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-28533-3_166

DO - 10.1007/978-3-030-28533-3_166

M3 - Chapter

AN - SCOPUS:85089631592

SN - 9783030285319

SP - 667

EP - 671

BT - Cardiac Electrophysiology

PB - Springer International Publishing

ER -

Shock termination of tachycardia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this